2-naphthol has been researched along with 5,8-dihydroxy-3-methyl-4-(9h)-naphtho(2,3-c)furanone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, S; Kawamoto, I; Matsuda, Y; Nakanishi, S; Yano, H | 1 |
| Aotani, Y; Saitoh, Y | 1 |
| Gunji, H; Tatsuta, K; Yoshimoto, T | 1 |
| Auer, M; Bauer, R; Buehler, C; Guenat, C; Harrer, N; Hintersteiner, M; Meisner, NC; Moss, S; Mueller, K; Naegeli, HU; Oberer, L; Ottl, J; Seifert, JM; Uhl, V; Woisetschlaeger, M | 1 |
| Andersson, T; Berglund, P; Leandersson, K; Linnskog, R; Moradi, F; Prasad, CP | 1 |
| Aguado, A; Anant, S; Blanco, FF; Brody, JR; Dixon, DA; Meisner-Kober, N; Padhye, S; Preet, R; Stevens, LE; Vishwakarma, V; Vyas, A; Weir, SJ; Xu, L | 1 |
| Beibel, M; Berry, D; Bhuju, S; Dammann, K; Ebner, F; Evstatiev, R; Gasche, C; Khare, V; Kovarik, P; Kuzyk, O; Lang, M; Loy, A; Meisner-Kober, N; Mesteri, I; Passecker, K; Roma, G; Sedlyarov, V | 1 |
| Hjelmeland, AB; King, PH; Nabors, LB; Wang, J | 1 |
| Li, X; Liu, Y; Wei, Y; Zhang, H; Zhang, M | 1 |
9 other study(ies) available for 2-naphthol and 5,8-dihydroxy-3-methyl-4-(9h)-naphtho(2,3-c)furanone
| Article | Year |
|---|---|
MS-444, a new inhibitor of myosin light chain kinase from Micromonospora sp. KY7123.
Topics: Animals; Chickens; Fermentation; Furans; Microbial Sensitivity Tests; Micromonospora; Molecular Structure; Myosin-Light-Chain Kinase; Naphthols | 1995 |
Structure determination of MS-444; a new myosin light chain kinase inhibitor.
Topics: Furans; Molecular Structure; Myosin-Light-Chain Kinase; Naphthols; Spectrum Analysis | 1995 |
Total synthesis of MS-444, a myosin light chain kinase inhibitor.
Topics: Enzyme Inhibitors; Furans; Myosin-Light-Chain Kinase; Naphthols | 1997 |
Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR.
Topics: Actinomyces; Anthracenes; Anti-Infective Agents; Antigens, Surface; Binding, Competitive; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; ELAV Proteins; ELAV-Like Protein 1; Fluorescence Polarization; Furans; Humans; Kinetics; Models, Theoretical; Molecular Sequence Data; Naphthols; Pyrones; RNA-Binding Proteins | 2007 |
Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration.
Topics: Cell Line, Tumor; Cell Movement; Cytoplasm; ELAV-Like Protein 1; Furans; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Humans; Matrix Metalloproteinase 9; Melanoma; Models, Biological; Molecular Weight; Naphthols; Protein Binding; Protein Transport; Recombinant Proteins; RNA, Messenger; Wnt-5a Protein | 2016 |
Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; ELAV-Like Protein 1; Furans; HCT116 Cells; HT29 Cells; Humans; Mice; Mice, Nude; Naphthols; Transfection; Xenograft Model Antitumor Assays | 2016 |
HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.
Topics: Adenomatous Polyposis Coli; Animals; Apoptosis; Carcinogenesis; Cell Proliferation; Chemokine CCL11; Colorectal Neoplasms; ELAV-Like Protein 1; Feces; Furans; Gastrointestinal Microbiome; HCT116 Cells; Humans; Inflammatory Bowel Diseases; Interleukin-18; Mice; Naphthols; RAW 264.7 Cells | 2017 |
Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; ELAV-Like Protein 1; Furans; Gene Expression Regulation, Neoplastic; Glioma; Humans; Naphthols; RNA Stability | 2019 |
HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer.
Topics: 3' Untranslated Regions; Animals; B7-H1 Antigen; ELAV-Like Protein 1; Furans; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Immunity; Interleukin-2; MARVEL Domain-Containing Proteins; Mice; Myelin Proteins; Naphthols; Neoplasms; Programmed Cell Death 1 Receptor; RNA, Messenger; T-Lymphocytes | 2021 |